Pharma Equity Group A/S (CPH:PEG)
Denmark flag Denmark · Delayed Price · Currency is DKK
0.0934
+0.0092 (10.93%)
Jul 28, 2026, 2:15 PM CET

Pharma Equity Group Financials Overview

Millions DKK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-25.29-25.29-37.48-25.03-11.28
Net Income
-25.38-25.38-40.61-24.35-9.44
Earnings Per Share
-0.02-0.02-0.04-0.02-0.01
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
0.50.54.234.232.83
Total Debt
8.068.0611.0530.220.58
Net Cash (Debt)
-7.56-7.56-6.81-25.992.25
Net Cash Growth
-----
Net Cash Per Share
-0.01-0.01-0.01-0.020.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-17.66-17.66-22.86-16.62-8.3
Capital Expenditures
----0.07-
Free Cash Flow
-17.66-17.66-22.86-16.7-8.3
Free Cash Flow Growth
-----